Studies of serotonin metabolites in body fluids in attempted suicide patien
ts and of post-mortem brain tissue of suicide victims have demonstrated the
involvement of the serotonergic neurotransmission system in the pathogenes
is of suicidal behaviour. Recently developed neuroimaging techniques offer
the unique possibility of investigating in vivo the functional characterist
ics of this system. In this study the 5-HT2a receptor population of patient
s who had recently attempted suicide was studied by means of the highly spe
cific radio-iodinated 5-MT2a receptor antagonist 4-amino-N-[1-[3-(4-fluorop
henoxy) propyl] -4-methyl-4-piperidinyl] -5-iodo-2-methoxybenzamide or I-12
3-5-I-R91150. Nine patients who had recently (1-7 days) attempted suicide a
nd 12 age-matched healthy controls received an intravenous injection of 185
MBq I-123-5-I-R91150 and were scanned with high-resolution brain single-ph
oton emission tomography (SPET), Stereotactic realigned images were analyse
d semi-quantitatively using predefined volumes of interest. Serotonin bindi
ng capacity was expressed as the ratio of specific to non-specific activity
. The cerebellum was used as a measure of non-specific activity. An age-dep
endent 5-HT2a binding index was found, in agreement with previous literatur
e, Deliberate self-harm patients had a significantly reduced mean frontal b
inding index after correction for age (P=0.002) when compared with controls
. The reduction was more pronounced among deliberate self-injury patients (
DSI) (P<0.001) than among deliberate self-poisoning patients (DSP). Frontal
binding index was significantly lower in DSI patients than in DSP suicide
attempters (P<0.001). It is concluded that brain SPET of the 5-MT2a seroton
in receptor system in attempted suicide patients who are free of drugs infl
uencing the serotonergic system shows in vive evidence of a decreased front
al binding index of the 5-HT2a receptor, indicating a decrease in the numbe
r and/or in the binding affinity of 5-MT2a receptors.